Premium Content Editorial content

Protecting biotech IP to support deal value

Inadequate or unsuitable intellectual property (IP) protection could allow competitors to more easily launch a competing product, jeopardizing the opportunity for meaningful return on investment and consequently potential dealmaking. This feature discusses key factors for biotechnology companies to consider in creating IP strategies to support value.

Please sign in or register for FREE

Register to BioPharma Dealmakers

From the publishers of Nature, the BioPharma Dealmakers website brings together life sciences companies and individuals looking to identify and attract partners and dealmaking opportunities. It provides insights into dealmaking trends from BioPharma Dealmakers Editors, profiles from companies looking to partner, tools for networking and sharing knowledge, and the opportunity for sponsoring companies to showcase their expertise. BioPharma Dealmakers is THE destination for partnering professionals looking to make connections and get the latest on their industry.


No comments yet.